VYNE Therapeutics Inc. (VYNE) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of$0.23. This compares to a loss of $0.22 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +43.48$0.29 per share when it actually produced a loss of $0.2, delivering a surprise of +31.03%.Over the last four quarters, the company ha ...